Pharmacological metabolism issues put patient safety at risk by raising the
possibility of side effects and inadequate treatment results. This summary attempts to
explain the challenges associated with drug metabolism, particularly long-term
polypharmacy with metabolites - when an unintended change has direct and clinically
meaningful effects. This is done through a series of cases and patient stories.
Metabolism typically consists of a series of enzymatic reactions that occur primarily in
the liver and result in drugs being converted into water-soluble forms for excretion.
Nevertheless, it is a factor that can be disrupted by genetic polymorphisms, liver
diseases affecting its expression or function, drug interactions, and age-related changes
in physiological mechanisms. Metabolites can lead to bioaccumulation of a drug, poor
therapeutic effects, or adverse events if metabolism is incomplete. A patient with a
CYP2D6 enzyme deficiency may convert codeine to morphine more slowly, resulting
in inadequate pain relief. Another example is a distant psychiatric patient with
underlying liver disease who experiences significant inadequacy of benzodiazepine
metabolism, leading to prolonged sedation and respiratory depression. There is also an
example of polypharmacy, in which a patient taking multiple medications, including a
strong CYP3A4 inhibitor, receives a toxic amount of a normally safe dose because the
metabolic clearance rate is reduced. They are important examples of incomplete drug
metabolism and underscore the imperative incorporation of precise, personalized
medicine techniques, including genetic testing, close monitoring of liver function tests
(which would account for gender differences in response), and thorough consideration
of possible interactions between pharmaceutical agents that contribute to individual
variability. This, in turn, allows healthcare professionals to provide more personalized
treatment, minimize the risk of side effects, and improve patient outcomes.
Keywords: Disease, Drug interactions, Drug metabolism, Personalized medicine techniques, Pharmacogenomics.
